Clinical trial
A Phase 3, Randomised, Double-Blind, Placebo-Controlled Multi-Centre Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo in Participants With Knee Osteoarthritis Pain
NCT06917404 is registered in ClinicalTrials.gov with Paradigm Biopharmaceuticals Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomised, Double-Blind, Placebo-Controlled Multi-Centre Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo in Participants With Knee Osteoarthritis Pain
- Lead sponsor
- Paradigm Biopharmaceuticals Ltd.
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- May 29, 2025
- Completion date
- July 31, 2027
- Enrollment
- 466 (estimated)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.